Van Nostrand Robert L's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Jun 21, 2024
- Accession no.
- 0000950170-24-076380
- Filed
- Jun 21, 2024
- Trade date
- Jun 18, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.52M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Nostrand Robert LCIK 0001225198 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Common Stock | MOption exerciseAcquired | +20,000 | $16.86 | +$337,200 | 29,690 | Direct | |
| Jun 18, 2024 | Common Stock | SSaleDisposed | −8,891 | $75.71 | −$673,137.61 | 20,799 | Direct | |
| Jun 18, 2024 | Common Stock | SSaleDisposed | −11,109 | $76.07 | −$845,061.63 | 9,690 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.